Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity — CARE-ROP

Retinopathy of Prematurity (ROP) Clinical Trial

Official title:
Multicenter Randomized Double Masked Parallel Design Exploratory Study to Assess Safety and Efficacy of Two Different Doses of Intravitreal Anti-VEGF Treatment With Ranibizumab (0.12 mg vs. 0.20 mg) in Infants With Retinopathy of Prematurity (ROP)

Status Completed

Clinical Trial Summary

This study is designed as an exploratory study to assess safety and efficacy of two different doses of the anti-VEGF agent ranibizumab (0.12 mg vs. 0.20 mg) in the treatment of infants with retinopathy of prematurity. Furthermore it shall help to improve safety in the treatment of ROP and provide explorative data on long-term effects of ranibizumab after intravitreal injection in neonates.

The primary objective is to assess clinical efficacy of ranibizumab in children with ROP

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02134457
Study type	Interventional
Source	University Hospital Freiburg
Contact
Status	Completed
Phase	Phase 2
Start date	August 2014
Completion date	January 2017

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04506619` - Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Completed	`NCT04004208` - Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy	Phase 3
Active, not recruiting	`NCT03253263` - A Clinical Efficacy and Safety Study of OHB-607 in Preventing Chronic Lung Disease in Extremely Premature Infants	Phase 2
Completed	`NCT02386839` - Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)	Phase 2
Withdrawn	`NCT01470430` - VEGF In Systemic Circulation Of ROP-infants	N/A
Completed	`NCT01054027` - Study on Effective Mydriasis in Premature Infants	N/A
Active, not recruiting	`NCT04015180` - Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090	Phase 3
Completed	`NCT01096784` - IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity	Phase 2
Completed	`NCT02640664` - Rainbow Extension Study	Phase 3
Terminated	`NCT01954082` - Inositol to Reduce Retinopathy of Prematurity	Phase 3